Trials / Completed
CompletedNCT03210909
Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
An intravenous infusion in healthy subjects to obtain information about the absorption, metabolism, and excretion (AME) of BMS-986231
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986231 | BMS-986231 |
Timeline
- Start date
- 2017-06-22
- Primary completion
- 2017-07-20
- Completion
- 2017-07-20
- First posted
- 2017-07-07
- Last updated
- 2017-08-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03210909. Inclusion in this directory is not an endorsement.